These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 928852)
61. Combination bacteriolytic therapy for the treatment of experimental tumors. Dang LH; Bettegowda C; Huso DL; Kinzler KW; Vogelstein B Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15155-60. PubMed ID: 11724950 [TBL] [Abstract][Full Text] [Related]
62. Combined effects of heat, nisin and acidification on the inactivation of Clostridium sporogenes spores in carrot-alginate particles: from kinetics to process validation. Naim F; Zareifard MR; Zhu S; Huizing RH; Grabowski S; Marcotte M Food Microbiol; 2008 Oct; 25(7):936-41. PubMed ID: 18721685 [TBL] [Abstract][Full Text] [Related]
63. [Experiments with hemosensitins from Clostridium butyricum]. Sachse H; Sachse R Z Gesamte Hyg; 1977 Oct; 23(10):759-62. PubMed ID: 602304 [No Abstract] [Full Text] [Related]
64. Production and characterization of pure Clostridium spore suspensions. Yang WW; Crow-Willard EN; Ponce A J Appl Microbiol; 2009 Jan; 106(1):27-33. PubMed ID: 19120612 [TBL] [Abstract][Full Text] [Related]
65. [Various results of the study on antigenic differences between Clostridium sordellii and Clostridium bifermentans]. Egorova GK; Fedorov IuM; Bocharova NG Zh Mikrobiol Epidemiol Immunobiol; 1978 Feb; (2):138. PubMed ID: 665020 [No Abstract] [Full Text] [Related]
66. Scintigraphic tumor localization in mice with radioiodinated anti-Clostridium antibodies. Altenbrunn HJ; Mehnert WH; Vogt R; Schmidt HE; Steenbeck L Int J Nucl Med Biol; 1981; 8(1):90-3. PubMed ID: 7228523 [No Abstract] [Full Text] [Related]
67. [Sporulating ability, toxigenicity, and biological and immunological properties of clostridia]. Nishida N Nihon Saikingaku Zasshi; 1973 Sep; 28(5):401-11. PubMed ID: 4586306 [No Abstract] [Full Text] [Related]
68. [Tumor therapy with parasites and microorganisms]. Gericke D Naturwissenschaften; 1965 Dec; 52(23):629-32. PubMed ID: 5873895 [No Abstract] [Full Text] [Related]
70. Immunotherapy: the treatment bug--fighting cancer with bacterial infection. Killock D Nat Rev Clin Oncol; 2014 Oct; 11(10):562. PubMed ID: 25178634 [No Abstract] [Full Text] [Related]
71. The tumour-Clostridium phenomenon: 50 years of developmental research (Review). Schmidt W; Fabricius EM; Schneeweiss U Int J Oncol; 2006 Dec; 29(6):1479-92. PubMed ID: 17088987 [TBL] [Abstract][Full Text] [Related]
72. Progress in clostridial oncolysis and diagnosis. Gericke D Rev Can Biol; 1977 Sep; 36(3):195-203. PubMed ID: 928852 [No Abstract] [Full Text] [Related]
73. [Experiments to improve the oncolysis-effect of clostridial-strain M55 (author's transl)]. Möse JR Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):541-5. PubMed ID: 543354 [TBL] [Abstract][Full Text] [Related]
74. [Serological studies using clostridium spores for tumor diagnosis. II. Studies of ethylnitrosourea induced tumors in rats]. Kretschmer H; Schöche J; Gräbber A Arch Geschwulstforsch; 1973; 41(2):114-9. PubMed ID: 4741521 [No Abstract] [Full Text] [Related]
75. [The use of clostridial antigens for a serological and autoradiographical early diagnosis of tumours (author's transl)]. Möse JR; Schwager J Zentralbl Bakteriol Orig A; 1978 Dec; 242(4):512-6. PubMed ID: 749418 [TBL] [Abstract][Full Text] [Related]
76. A theoretical models of oncolysis by Clostridium oncolyticum M 55 ATCC 13,732. Brantner H; Schwager J Arch Geschwulstforsch; 1980; 50(7):601-12. PubMed ID: 6263207 [TBL] [Abstract][Full Text] [Related]